Marathon Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $4.45M | Sell |
|
|||||
2022
Q1 | $4.56M | Sell |
|
|||||
2021
Q4 | $4.64M | Sell |
|
|||||
2021
Q3 | $4.05M | Buy |
|
|||||
2021
Q2 | $4.21M | Sell |
|
|||||
2021
Q1 | $3.79M | Buy |
|
|||||
2020
Q4 | $3.71M | Sell |
|
|||||
2020
Q3 | $4.27M | Sell |
|
|||||
2020
Q2 | $4.8M | Buy |
|
|||||
2020
Q1 | $2.86M | Sell |
|
|||||
2019
Q4 | $3.55M | Buy |
|
|||||
2019
Q3 | $3.03M | Buy |
|
|||||
2019
Q2 | $2.84M | Sell |
|
|||||
2019
Q1 | $2.99M | Sell |
|
|||||
2018
Q4 | $2.77M | Sell |
|
|||||
2018
Q3 | $3.15M | Sell |
|
|||||
2018
Q2 | $3.21M | Buy |
|
|||||
2018
Q1 | $3.1M | Buy |
|
|||||
2017
Q4 | $2.45M | Sell |
|
|||||
2017
Q3 | $2.82M | Buy |
|
|||||
2017
Q2 | $2.99M | Buy |
|
|||||
2017
Q1 | $2.9M | Buy |
|
|||||
2016
Q4 | $2.64M | Buy |
|
|||||
2016
Q3 | $586K | Buy |
|